Phase 1 calls on scientific, technical, and clinical experts to submit innovative detection methods that will advance Lyme disease diagnostics.
A prize competition to accelerate the development of Lyme disease diagnostics
About the competition
The goal of the LymeX Diagnostics Prize is to develop diagnostics that can accurately detect active Lyme disease infections in people. The multiphase competition will nurture the development of innovative solutions toward Food and Drug Administration review. Phase 1 will award $1 million; at the discretion of the U.S. Department of Health and Human Services (HHS) and the Steven & Alexandra Cohen Foundation, additional phases may follow. The competition anticipates awarding up to $10 million in prizes across all potential phases, subject to availability of funds.
Phase 1 timeline
Phase 1 is open to all eligible entrants to submit concept papers and plans for development.
We are here
Competition launch
May 17, 2022
Submission deadline
August 8, 2022
Judging
September 2022
Phase 1 winner announcement
October 2022
Phase 2 launch
Late 2022
Phase 1 prizes
A judging panel will recommend up to 10 winners according to official Phase 1 evaluation criteria. Phase 1 winners will receive an equal share of the $1 million Phase 1 prize pool and will have the opportunity to participate in a planned Phase 2.
Note: No future phases or prizes are guaranteed beyond Phase 1. Future phases may be launched at the discretion of HHS and Cohen Foundation, and any prize amounts beyond Phase 1 are anticipated and subject to future availability of funds.
$1 million
With $10 million anticipated total prize pool planned across three phases